For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Australasian Menopause Society, Position Statements

Australasian Menopause Society, Position Statements
The Australasian Menopause Society (AMS) is a scientific society with over 700 members. It rigorously assesses issues that may arise in management the menopause and publishes an AMS position statement where required
Friday 25 August 2017